Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD.
Saved in:
| Title: | Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD. |
|---|---|
| Authors: | Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA., Rodriguez-Roisin R; Universitat de Barcelona, Hospital Clínic-The August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Reisner C; Pearl - A member of the AstraZeneca Group, Morristown, NJ, USA.; AstraZeneca, Gaithersburg, MD, USA., Maes A; Pearl - A member of the AstraZeneca Group, Morristown, NJ, USA., Siddiqui S; AstraZeneca, Gaithersburg, MD, USA., Martin UJ; AstraZeneca, Gaithersburg, MD, USA. |
| Source: | International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2018 Mar 21; Vol. 13, pp. 945-953. Date of Electronic Publication: 2018 Mar 21 (Print Publication: 2018). |
| Publication Type: | Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101273481 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2005 (Electronic) Linking ISSN: 11769106 NLM ISO Abbreviation: Int J Chron Obstruct Pulmon Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1178-2005 |
|---|---|
| DOI: | 10.2147/COPD.S154988 |
